Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing-Reference-Cited by-同舟云学术

Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing

Published:2015-08-05 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Alkner Sara,Tang Man-Hung Eric,Brueffer Christian,Dahlgren Malin,Chen Yilun,Olsson Eleonor,Winter Christof,Baker Sara,Ehinger Anna,Rydén Lisa,Saal Lao H.,Fernö Mårten,Gruvberger-Saal Sofia K.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0608-x.pdf

Reference26 articles.

1. Alkner S, Bendahl PO, Ferno M, Manjer J, Ryden L. Prediction of outcome after diagnosis of metachronous contralateral breast cancer. BMC Cancer. 2011;11:114.

2. Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, et al. Patterns of metastasis in women with metachronous contralateral breast cancer. Br J Cancer. 2012;107:221–3.

3. Vichapat V, Gillett C, Fentiman IS, Tutt A, Holmberg L, Luchtenborg M. Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways. Eur J Cancer. 2011;47:1919–27.

4. Vichapat V, Garmo H, Holmqvist M, Liljegren G, Warnberg F, Lambe M, et al. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. J Clin Oncol. 2012;30:3478–85.

5. Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, Ross RK. Clonal analysis of bilateral breast cancer. Clin Cancer Res. 1996;2:743–8.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-derived organoid elucidates the identical clonal origin of bilateral breast cancer with diverse molecular subtypes;Frontiers in Oncology;2024-05-10

2. Determining the Need for Metastatic Staging in Patients with Bilateral Breast Cancers;Current Oncology;2024-04-02

3. In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model;Cost Effectiveness and Resource Allocation;2023-11-10

4. In Situ Breast Cancer Surgeries in Sweden: Lumpectomy or Mastectomy? - A Cost-Utility Analysis in a 30-Year Time Period Using Markov Model;2023-07-07

5. Periostin+ Stromal Cells Guide Lymphovascular Invasion by Cancer Cells;Cancer Research;2023-05-19